European Archives - Page 786 of 1345 - European Medical Journal

EMJ Hepatology 9.1 Feature Image

Review of International Liver Congress 2021

PICTURESQUE Geneva, Switzerland, encircling Lac Léman with the famous Jet d’Eau fountain and overlooked by the Alps, would have…

EMJ Hepatology 9.1 Feature Image

EMJ Hepatology 9.1 2021

Welcome to the latest issue of EMJ Hepatology! Included is an impressive collection of the latest research, alongside our review of the 56th annual International Liver Congress (ILC), hosted online by the European Association for Study of the Liver (EASL). Highlights, interviews, and breaking news from this virtual event are shared in this issue.

Interview: Thomas Berg

The truth is my interest and fascination for liver and hepatology was very much influenced by my father…

EMJ Hepatology 9.1 Feature Image

Referral of Patients with Non-alcoholic Fatty Liver Disease with Significant Fibrosis from Primary Care to Secondary Care in Belgium

Non-alcoholic fatty liver disease (NAFLD) is becoming the most frequent cause of chronic liver disease worldwide. The stage of fibrosis…

EMJ Hepatology 9.1 Feature Image

Gene Editing to Treat Hypercholesterolaemia and Primary Hyperoxaluria

THE INTERNATIONAL Liver Congress (ILC) 2021 of the The European Association for the Study of the Liver (EASL) invited three speakers…

EMJ Hepatology 9.1 Feature Image

Editor’s Pick: Elevated Glucagon in a Patient with Necrolytic Acral Erythema: A Case Report and Review of the Literature

Necrolytic acral erythema (NAE) was first described in 1996 by el Darouti and Abu el Ela in Egypt.1 It is most…

Interview: Stephen Ryder

Hepatitis C virus (HCV) was discovered when I was a trainee and was a huge scientific breakthrough.

EMJ Hepatology 9.1 Feature Image

MicroRNA-27a-3p Modulates FoxO1 to Induce Tumour-Like Phenotypes in Bile Ducts

The authors analyse the miR landscape of CCA and non-malignant livers to define their roles in orchestrating gene regulation and promoting CCA development.

EMJ Hepatology 9.1 Feature Image

A MET-Agonistic Antibody Mimicking Hepatocyte Growth Factor Accelerates Liver Regeneration and Improves Survival in Mice Undergoing Carbon Tetrachloride Exposure and Partial Hepatectomy

Small-for-size syndrome (SFSS) is defined by prolonged cholestasis, coagulopathy, and ascites within the first week of liver…

Interview: Kieron Lim

Research in the field of HCC has enabled us to better understand the molecular signatures, tumour biology…